Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  gadoxetate disodium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
Health Economic Evaluation of Primovist-enhanced Liver MRI
Phase: Phase IV
Type: Diagnostic, Health services research
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91789, 312041, 2008-000583-16, NCT00764621
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Completed
Age: 2 months to 18 years
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13729, NCT01043523
Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN100405CE2010, NCT01255007
Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients
Phase: No phase specified
Type: Screening
Status: Closed
Age: 20 and over
Sponsor: Other
Protocol IDs: AMC2011-0587, NCT01446666
Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma
Phase: No phase specified
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: LIFE_ISS_2011, NCT01490203
Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Asklepios, NCT01522209
The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: R11-153, 117354, NCT01673802
Start Over